PT1458390E - Um método para tratar infecções bacterianas utilizando gemifloxacina ou um seu sal e um agente antibacteriano carbapenem - Google Patents

Um método para tratar infecções bacterianas utilizando gemifloxacina ou um seu sal e um agente antibacteriano carbapenem Download PDF

Info

Publication number
PT1458390E
PT1458390E PT02795443T PT02795443T PT1458390E PT 1458390 E PT1458390 E PT 1458390E PT 02795443 T PT02795443 T PT 02795443T PT 02795443 T PT02795443 T PT 02795443T PT 1458390 E PT1458390 E PT 1458390E
Authority
PT
Portugal
Prior art keywords
gemifloxacin
salt
bacterial infections
antibacterial agent
treating bacterial
Prior art date
Application number
PT02795443T
Other languages
English (en)
Inventor
Nancy Niconovich
Stephen Rittenhouse
Lynn Mccloskey
Kyong-Sook Paek
Mu-Yong Kim
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of PT1458390E publication Critical patent/PT1458390E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02795443T 2001-11-30 2002-11-29 Um método para tratar infecções bacterianas utilizando gemifloxacina ou um seu sal e um agente antibacteriano carbapenem PT1458390E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33513101P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
PT1458390E true PT1458390E (pt) 2008-10-02

Family

ID=23310394

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02795443T PT1458390E (pt) 2001-11-30 2002-11-29 Um método para tratar infecções bacterianas utilizando gemifloxacina ou um seu sal e um agente antibacteriano carbapenem

Country Status (13)

Country Link
US (1) US20050020567A1 (pt)
EP (1) EP1458390B1 (pt)
AT (1) ATE404197T1 (pt)
AU (1) AU2002360216A1 (pt)
CA (1) CA2468033C (pt)
CY (1) CY1108472T1 (pt)
DE (1) DE60228324D1 (pt)
DK (1) DK1458390T3 (pt)
ES (1) ES2312654T3 (pt)
MX (1) MXPA04005178A (pt)
NO (1) NO331599B1 (pt)
PT (1) PT1458390E (pt)
WO (1) WO2003045389A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797879A4 (en) * 2004-10-08 2009-05-06 Dainippon Sumitomo Pharma Co NEW ANTIMICROBIAL MEDICAMENT
US9292565B2 (en) * 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
CA2411944C (en) * 2000-06-09 2010-12-14 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices

Also Published As

Publication number Publication date
NO331599B1 (no) 2012-02-06
CA2468033A1 (en) 2003-06-05
CY1108472T1 (el) 2014-04-09
MXPA04005178A (es) 2004-08-11
EP1458390A1 (en) 2004-09-22
WO2003045389A1 (en) 2003-06-05
EP1458390B1 (en) 2008-08-13
EP1458390A4 (en) 2007-07-04
US20050020567A1 (en) 2005-01-27
AU2002360216A1 (en) 2003-06-10
NO20042660L (no) 2004-06-24
ES2312654T3 (es) 2009-03-01
DE60228324D1 (de) 2008-09-25
CA2468033C (en) 2008-02-12
ATE404197T1 (de) 2008-08-15
DK1458390T3 (da) 2008-12-15

Similar Documents

Publication Publication Date Title
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
TW200507841A (en) Antibacterial agents
MY138285A (en) Fab i inhibitors
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
AU2003291227A8 (en) Antibacterial agents
WO2005046579A3 (en) Defined dose therapeutic phage
HUE041133T2 (hu) Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
AU2003303956A8 (en) Antibacterial agents
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
WO2005118613A3 (de) Antibakterielle amid-makrozyklen
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
AU7594301A (en) Derivatives of laspartomycin and preparation and use thereof
PT1223935E (pt) Utilização de compostos de gemifloxacina contra bactérias
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
MXPA04005178A (es) Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem.
WO2005053613A3 (en) Combinations for the treatment of fungal infections
AUPR916101A0 (en) Method of treating halitosis
AU2003267962A8 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
AU2003209241A1 (en) Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections